EntryPoint Capital »

Esperion Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $87k 24k 3.70

More positions owned by EntryPoint Capital

Charles Schwab Corporation (SCHW)
PNC Financial Services (PNC)
Ameriprise Financial (AMP)
Target Corporation (TGT)
Ares Management Corporation Cl A Com Stk (ARES)
UMH Properties (UMH)
Vici Pptys (VICI)
TJX Companies (TJX)
Service Corporation International (SCI)
Zoetis Cl A (ZTS)
Honeywell International (HON)
State Street Corporation (STT)
Marsh & McLennan Companies
News Corp Cl A (NWSA)
RBC Bearings Incorporated (RBC)

View all positions for EntryPoint Capital

Top funds holding Esperion Therapeutics

BlackRock
Vanguard Group
Two Seas Capital
Daniel D. Thurber
OrbiMed Advisors
State Street Corporation
Geode Capital Management
Marshall Wace
PenderFund Capital Management
AIGH Capital Management
Eversept Partners
Nuveen
Royce & Associates
Goldman Sachs Group
Two Sigma Investments

View all funds holding Esperion Therapeutics